NMR Based Metabolomics Kinetics in ARDS Patients
Recruiting now
Conditions studied: ARDS
In brief
Acute respiratory distress syndrome (ARDS) is a life-threatening condition requiring respiratory support to maintain oxygenation. Very few biomarkers about ARDS have been identified but none of them has a sufficient specificity or sensitivity to characterize by itself the severity of lung condition. Investigators hypothesize that there is considerable change occurring in metabolic profiles in mild, moderate, and severe ARDS in comparison to healthy cohort, which can be detectable through serum analysis using NMR based metabolomics study. This research would help to understand metabolomics kinetics during the ARDS disease progression. Overall, NMR-based metabolomics study would provide an insight into the mediators involved in pathogenesis and progression of ARDS.
Key facts
- Study ID
- NCT06036056
- Run by
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- People needed
- 120
- Starts
- 2023-09-13
- Expected to finish
- 2025-09-01
- Last updated by the study team
- 2024-11-27
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Critically ill adult patients having mild ARDS with onset less than 72 hours
You may not qualify if…
- Age less than 18 years or more than 65 years
- Expected survival <72 hours
- Refusal from family member
Where it is running
- Centre of Biomedical Research — Lucknow, Uttar Pradesh, India (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.